Identifying and Quantifying Mutagenic Impurities in Pharmaceutical Products

June 16, 2020

LCGC E-Books

LCGC E-Books, LCGC E-Books-07-20-2020, Issue 17
Page Number: 17–26

Meeting detection challenges presented by nitrosamine impurities Determination of NDMA and nitrosamine impurities using triple-quadrupole LC/MS Determination of genotoxic impurities in ranitidine APIs and drug products